| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 251.65B | 258.37B | 248.12B | 218.93B | 208.86B | 179.75B |
| Gross Profit | 217.83B | 211.63B | 214.99B | 188.12B | 193.43B | 162.70B |
| EBITDA | 48.51B | 63.97B | 52.48B | 47.22B | 44.20B | 32.04B |
| Net Income | 34.52B | 37.67B | 30.37B | 26.39B | 24.67B | 16.66B |
Balance Sheet | ||||||
| Total Assets | 13.57T | 13.53T | 13.28T | 13.52T | 13.18T | 14.17T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.58T | 1.89T | 2.21T | 2.23T | 3.61T |
| Total Debt | 2.12T | 1.67T | 1.99T | 2.39T | 1.96T | 5.56T |
| Total Liabilities | 12.85T | 12.76T | 12.57T | 12.80T | 12.53T | 13.50T |
| Stockholders Equity | 715.92B | 760.97B | 703.74B | 716.93B | 651.62B | 670.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 94.68B | -403.43B | 0.00 | -1.64T | 1.82T |
| Operating Cash Flow | 0.00 | 103.03B | -392.13B | 0.00 | -1.63T | 1.83T |
| Investing Cash Flow | 0.00 | -528.60B | 77.68B | 144.98B | 252.14B | -170.96B |
| Financing Cash Flow | 0.00 | 89.34B | -8.12B | 49.79B | -5.20B | -8.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥131.69B | 11.66 | ― | 2.71% | 21.01% | 42.25% | |
70 Outperform | ¥175.81B | 16.10 | 3.68% | 2.26% | 23.47% | 44.30% | |
68 Neutral | ¥1.26T | 14.50 | 8.24% | 3.06% | 22.25% | 18.47% | |
66 Neutral | ¥606.57B | 15.52 | 5.53% | 2.02% | 5.69% | 24.72% | |
65 Neutral | ¥158.28B | 11.05 | ― | 2.29% | 9.41% | 45.91% | |
65 Neutral | ¥86.36B | 10.26 | ― | 2.29% | 11.72% | 14.29% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |